About MetroMedi
MetroMedi is a Healthcare company based in Hyderabad (India) founded in 2018 by Dileep Byra Chakravarthy and Maruthi Medisetti. Online drug store products for healthcare and nutrition are provided. MetroMedi has raised $1.95 million across 3 funding rounds from investors including TGV Prasad, TGN Aruna Kumari and GP Rao. MetroMedi was last valued at $1.86 million in March 2021. Its Indian entity Metromedi Health Technologies Private Limited reported revenue of ₹60.28 Cr. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include Digi-Prex, Pharmallama and Apkamedical; 2 of its 3 listed competitors have raised funding.
Company details
MetroMedi was founded in 2018 in Hyderabad, India, as an online drug store in the healthcare sector. Products focused on diabetic care, general healthcare, personal care, and nutrition are offered through its platform. Online purchases are supported with or without prescriptions, enabling access to these items for users across the region. Operations are centered on e-commerce delivery of medical and wellness goods.
- Headquarters Hyderabad, India
- Founders Dileep Byra Chakravarthy, Maruthi Medisetti
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website metromedi.com
- Social X Facebook
- Legal Name Metromedi Health Technologies Private Limited
- Date of Incorporation 20 Mar, 2018
- Jurisdiction Manikonda, Telangana, India
- Annual Revenue₹60.28 Cr
FY 2023 · +9% YoY
- Net Profit₹7.4 Lakh
FY 2023 · 0% margin
- EBITDA₹1.34 Cr
FY 2023 · 2% margin
- Total Equity Funding$1.95M (USD)
in 3 rounds
- Latest Funding Round$237.89K (USD), Angel Round
Mar 2021
Associated legal entities of MetroMedi
MetroMedi operates through Metromedi Health Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Metromedi Health Technologies Private Limited CIN U52609TG2018PTC123145 | Active | 20 Mar 2018 | Manikonda, Telangana | ₹60.3 Cr | 19 | 2 | View details |
Funding Insights of MetroMedi
MetroMedi has successfully raised a total of $1.95M across 3 strategic funding rounds. The most recent funding activity was a Angel Round of $237.89 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.95M
- Total Rounds 3
- Last Round Angel Round — $237,888
- First Round $1.5M
(Mar 2019)
- Investors Count 4
All 3 funding rounds of MetroMedi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $237,888 | Angel Round | $1.86M | TGV Prasad, TGN Aruna Kumari | – |
| Jan 2020 | $209,169 | Angel Round | $1.32M | TGV Prasad, TGN Aruna Kumari | – |
| Mar 2019 | $1.5M | Angel Round | – | TGN Aruna Kumari, GP Rao |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2021 | $1.86M | •••••••• |
| Jan 2020 | $1.32M | •••••••• |
| Mar 2019 | $••••• | •••••••• |
Full valuation and stage history of MetroMedi
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $1.86M (Mar 2021). 4 investors in total: 0 institutional and 4 angel.
Investors in MetroMedi
MetroMedi has secured backing from 4 investors, including angel investors. Prominent investors backing the company include TGV Prasad, TGN Aruna Kumari and GP Rao.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
TP TGV Prasad | unknown_30a36899ce4749fca | |||
TA TGN Aruna Kumari | unknown_7b55e9d429f144a7b | |||
GR GP Rao | unknown_8369b18ea7694e389 | |||
DB Dileep Byra Chakravarthy | unknown_d04e4cb1f93840628 |
Investor details for MetroMedi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Metromedi Health Technologies Private Limited (MetroMedi)
Metromedi Health Technologies Private Limited is the primary company behind MetroMedi. The board of Metromedi Health Technologies Private Limited currently have 2 directors; the longest-serving is Janaki Chakravarthi Byra, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Janaki Chakravarthi Byra DIN 06932981 | Director | 20 Mar 2018 | 8 yrs 7 mo | Metromedi Health Technologies Private Limited |
| Dileep Byra Chakravarthy DIN 00554725 | Managing Director | 28 Nov 2018 | 7 yrs 10 mo | Metromedi Health Technologies Private Limited |
People of MetroMedi
2 people are tracked at MetroMedi (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
Maruthi Medisetti | Co-Founder | Leadership |
Complete people profiles for MetroMedi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MetroMedi
Figures of Metromedi Health Technologies Private Limited, the primary company behind MetroMedi, for FY 2023. Revenue was ₹60.28 Cr (+9% year on year). Net profit was ₹7.4 Lakh (0% margin). EBITDA was ₹1.34 Cr (2% margin). Revenue has grown at a compounded annual rate of +23% over three years and +278% over five years.
- ₹60.28 CrRevenue · FY 2023 · +9% YoY
- ₹7.4 LakhNet profit · 0% margin
- ₹1.34 CrEBITDA · 2% margin
- ₹10.83 CrPaid-up capital
- 19Employees (provident fund records)
- +23%Revenue CAGR, 3 years
- +278%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Metromedi Health Technologies Private Limited are on its company page.
Detailed financial statements for MetroMedi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of MetroMedi
4 dated milestones of MetroMedi across 3 years, from founding to its latest funding, stage changes and deals.
- Founded MetroMedi is founded.
- Funding First funding round of $1.5M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $238K.
Competitors of MetroMedi
MetroMedi has 3 listed competitors in our database, 2 of them funded. They include Digi-Prex, Pharmallama and Apkamedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| digi-prex.com | 2019 | Hyderabad, India | $5.5M | 5 | Prescriptions are uploaded online for medicine delivery and reordering. | |
| pharmallama.com | 2020 | Bengaluru, India | $241,518 | 16 | Online platform for the purchase of medicines | |
| apkamedical.com | 2020 | Morena, India | Operates a digital marketplace for online medicine purchases. |
Detailed competitors of MetroMedi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MetroMedi
The website of MetroMedi (metromedi.com) receives about 4.4K visits a month.
- Monthly visits4.4K
▼ 18.7% vs previous month
Websites whose visitors overlap most with MetroMedi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| healthurwealth.com | 100% | 8K | #1,532,049 | View details |
Top companies in Digital Health & Telemedicine
3 companies that operate in the same segment as MetroMedi (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of an online pharmacy with doctor listing and teleconsultation services | 2015 | Delhi, Delhi, India | USD 230.8 M | USD 328.97 M | 5,212 | |
Online platform offering multiple healthcare services | 2013 | Bengaluru, Karnataka, India | USD 199.22 M | USD 62.4 M | 52 | |
An online marketplace for healthcare products is operated. | 2011 | Kolkata, West Bengal, India | USD 38.26 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Metromedi
Complete news archive for MetroMedi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MetroMedi
MetroMedi was founded in 2018 and raised its 1st funding round 1 year after it was founded.
MetroMedi is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
MetroMedi is a funded company, having raised a total of $1.95M across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $1.5M, raised on Mar 2019.
The primary company behind MetroMedi, Metromedi Health Technologies Private Limited, reported revenue of ₹60.28 Cr for FY 2023, up 9% year on year.
MetroMedi was founded in 2018 in Hyderabad, India, as an online drug store in the healthcare sector. Products focused on diabetic care, general healthcare, personal care, and nutrition are offered through its platform. Online purchases are supported with or without prescriptions, enabling access to these items for users across the region. Operations are centered on e-commerce delivery of medical and wellness goods.
MetroMedi's top competitors include Digi-Prex, Pharmallama and Apkamedical.
MetroMedi has 4 investors. Key investors include TGV Prasad, TGN Aruna Kumari, GP Rao, and Dileep Byra Chakravarthy.
The valuation of MetroMedi is $1.86M as of Mar 2021.
MetroMedi operates through Metromedi Health Technologies Private Limited.
The legal entities of MetroMedi currently have 2 directors, including Dileep Byra Chakravarthy, Janaki Chakravarthi Byra.